Development and validation of a clinical prediction model for overactive bladder in type 2 diabetes: a pathophysiology-informed approach

Read full text Summarise with VIRAT
Authors: Meiyuan Lv, Guangxu Fu, Dongfeng Yi, Zhihua Zhang, Liangbing Liu
Cited by: 0
References: 44

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Overactive bladder (OAB) is a highly prevalent and burdensome complication of type 2 diabetes mellitus (T2DM), with a pathophysiology distinct from idiopathic OAB. Current management relies on symptom-based diagnosis, lacking tools for proactive risk stratification that reflect its multifactorial origins in neuropathy, microvascular injury, and inflammation. In this retrospective cohort study, we developed and temporally validated a clinical prediction model using data from 1531 patients with T2DM. The model was derived via multivariable logistic regression with backward selection in a development cohort (n = 810, Jan 2018-Dec 2021) and tested in an independent validation cohort (n = 721, Jan 2022-Feb 2025). OAB was defined by the Overactive Bladder Symptom Score (OABSS). Model performance was assessed by discrimination (AUC), calibration, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) analysis elucidated variable contributions. Seven readily available clinical parameters were retained in the final model: diabetic peripheral neuropathy (DPN), HbA1c, urinary albumin-to-creatinine ratio (UACR) category, neutrophil-to-lymphocyte ratio (NLR), age, the Triglyceride-Glucose (TyG) Index, and post-void residual volume (PVR). The model demonstrated excellent discrimination (AUC 0.880 [0.844–0.917] in development; 0.858 [0.814–0.902] in validation) and was well-calibrated. Decision curve analysis confirmed clinical utility across a wide risk threshold range. SHAP analysis identified DPN as the strongest predictor, validating the model’s alignment with the underlying pathophysiological hierarchy. We developed and validated a practical, pathophysiology-informed prediction model that accurately stratifies the risk of OAB in patients with T2DM. This tool integrates key domains of diabetic complications into a single assessment, enabling a shift towards proactive, personalized risk communication and targeted surveillance for high-risk individuals.

Fields of Study & Subjects

Urinary Bladder and Prostate Research Pelvic floor disorders treatments Urinary Tract Infections Management

Publication details

Journal / source
European journal of medical research
Volume
31
Issue
1
Publication date
23 March 2026
Language
EN